Results 1 to 10 of about 21,772 (207)

Activated Ras signaling pathways and reovirus oncolysis: an update on the mechanism of preferential reovirus replication in cancer cells [PDF]

open access: yesFrontiers in Oncology, 2014
The development of wild-type, unmodified Type 3 Dearing (T3D) strain reovirus as an anticancer agent has currently expanded to 32 clinical trials (both completed and ongoing) involving reovirus in the treatment of cancer.
Jun eGong, Monica Mirela Mita
doaj   +4 more sources

Preinduced reovirus-specific T-cell immunity enhances the anticancer efficacy of reovirus therapy [PDF]

open access: yesJournal for ImmunoTherapy of Cancer, 2022
Background Many solid tumors do not respond to immunotherapy due to their immunologically cold tumor microenvironment (TME). We and others found that oncolytic viruses (OVs), including reovirus type 3 Dearing, can enhance the efficacy of immunotherapy by
Rob C Hoeben   +11 more
doaj   +2 more sources

Activation of p53 by chemotherapeutic agents enhances reovirus oncolysis. [PDF]

open access: yesPLoS ONE, 2013
Mammalian reovirus is a benign virus that possesses the natural ability to preferentially infect and kill cancer cells (reovirus oncolysis). Reovirus exploits aberrant Ras signalling in many human cancers to promote its own replication and spread.
Da Pan   +6 more
doaj   +2 more sources

Oncolytic reovirus in canine mast cell tumor. [PDF]

open access: yesPLoS ONE, 2013
The usage of reovirus has reached phase II and III clinical trials in human cancers. However, this is the first study to report the oncolytic effects of reovirus in veterinary oncology, focusing on canine mast cell tumor (MCT), the most common cutaneous ...
Chung Chew Hwang   +11 more
doaj   +2 more sources

Reovirus resistance in tumors mediated by elevated ISG expression: overcoming therapeutic resistance via JAK/STAT pathway modulation [PDF]

open access: yesVirology Journal
Background Oncolytic viruses such as reovirus hold significant promise for cancer therapy, but their efficacy varies across tumor types due to heterogeneous tumor cell sensitivity to reovirus.
Yuxin Yang   +8 more
doaj   +2 more sources

Ataxin-2-like promotes translation of nonpolyadenylated reovirus mRNA [PDF]

open access: yesNature Communications
Mammalian orthoreovirus (reovirus) nonstructural protein μNS nucleates viral factories (VFs), which are sites of viral genome replication, protein synthesis, and particle assembly.
Xayathed Somoulay   +10 more
doaj   +2 more sources

Oncolytic reovirus: tumor-microenvironment remodeling, engineering constraints, and translational strategies [PDF]

open access: yesFrontiers in Immunology
Oncolytic reovirus (ReoV) has emerged as a promising cancer immunotherapy platform because of its natural tumor tropism and immunostimulatory properties.
Rui Li   +11 more
doaj   +2 more sources

Reovirus: Friend and Foe [PDF]

open access: yesCurrent Clinical Microbiology Reports, 2019
Mammalian orthoreovirus (reovirus) is a powerful tool for studying viral replication and pathogenesis. Most reovirus infections are subclinical, however recent work has catapulted reovirus into the clinical spotlight.Owing to its capacity to kill cancer cells more efficiently than normal cells, reovirus is under development as a therapeutic for a ...
Karl W. Boehme
exaly   +3 more sources

Paired immunoglobulin-like receptor B is an entry receptor for mammalian orthoreovirus

open access: yesNature Communications, 2023
Mammalian orthoreovirus (reovirus) infects most mammals and is associated with celiac disease in humans. In mice, reovirus infects the intestine and disseminates systemically to cause serotype-specific patterns of disease in the brain.
Pengcheng Shang   +14 more
doaj   +1 more source

Reovirus infection of tumor cells reduces the expression of NKG2D ligands, leading to impaired NK-cell cytotoxicity and functionality

open access: yesFrontiers in Immunology, 2023
In recent years, reoviruses have been of major interest in immunotherapy because of their oncolytic properties. Preclinical and clinical trials, in which reovirus was used for the treatment of melanoma and glioblastoma, have paved the way for future ...
Raghad Khaleafi   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy